| Product Code: ETC7810419 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kenya Pharmacogenetic Testing Market Overview |
3.1 Kenya Country Macro Economic Indicators |
3.2 Kenya Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Kenya Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Kenya Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Kenya Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Kenya Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Kenya Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Kenya Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Kenya Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Kenya Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Kenya Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Kenya Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Rising prevalence of chronic diseases in Kenya |
4.2.3 Government initiatives to promote precision medicine |
4.3 Market Restraints |
4.3.1 Limited awareness and understanding of pharmacogenetic testing among healthcare professionals and patients |
4.3.2 High costs associated with pharmacogenetic testing |
4.3.3 Lack of regulatory framework for pharmacogenetic testing in Kenya |
5 Kenya Pharmacogenetic Testing Market Trends |
6 Kenya Pharmacogenetic Testing Market, By Types |
6.1 Kenya Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Kenya Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Kenya Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Kenya Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Kenya Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Kenya Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Kenya Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Kenya Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Kenya Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Kenya Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Kenya Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Kenya Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Kenya Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Kenya Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Kenya Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Kenya Pharmacogenetic Testing Market Export to Major Countries |
7.2 Kenya Pharmacogenetic Testing Market Imports from Major Countries |
8 Kenya Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenetic testing services |
8.2 Percentage of healthcare professionals trained in pharmacogenetic testing |
8.3 Adoption rate of pharmacogenetic testing by healthcare providers |
8.4 Rate of reimbursement for pharmacogenetic testing by health insurance companies |
8.5 Number of research studies and publications on pharmacogenetic testing in Kenya |
9 Kenya Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Kenya Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Kenya Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Kenya Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Kenya Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Kenya Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Kenya Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Kenya Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Kenya Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Kenya Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Kenya Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here